Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus
Aim. To evaluate the effects of insulin and other glucose-lowering medications on platelet function and coagulation haemostasis in patients with Type 2 diabetes mellitus (DM-2). Material and methods. The study included 147 patients with DM-2, aged 49—60 years (mean age 54 years), not receiving any g...
Main Authors: | G. G. Petrik, S. A. Pavlishchuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2041 |
Similar Items
-
Hemostasis effects of various glucose-lowering medications and angiopathy prevention
by: G. G. Petrik, et al.
Published: (2011-06-01) -
The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy
by: Saberi M, et al.
Published: (2020-06-01) -
Oral anti-diabetics for gestational diabetes mellitus – where do we stand?
by: Delia Cudalba, et al.
Published: (2020-09-01) -
Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus
by: Ali I Al-Gareeb, et al.
Published: (2016-01-01) -
Gestational diabetes mellitus—right person, right treatment, right time?
by: Robert S. Lindsay, et al.
Published: (2017-08-01)